Could this be the case of a blown-up long-term opportunity? Intellia Therapeutics Inc (NTLA)
At the time of writing, Intellia Therapeutics Inc [NTLA] stock is trading at $9.16, down -3.17%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NTLA shares have gain 7.76% over the last week, with a monthly amount glided 11.98%, and seem […]
Intellia Therapeutics Inc (NTLA) stock: 12-month forecast projects 93.16% potential return%
At the time of writing, Intellia Therapeutics Inc [NTLA] stock is trading at $9.06, up 6.59%. An important factor to consider is whether the stock is rising or falling in short-term value. The NTLA shares have gain 5.96% over the last week, with a monthly amount glided 25.31%, and seem to be holding up well […]
Intellia Therapeutics Inc (NTLA) stock poised to deliver a potential return of 110.34%
At the time of writing, Intellia Therapeutics Inc [NTLA] stock is trading at $8.32, down -2.69%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The NTLA shares have gain 14.76% over the last week, with a monthly amount glided 12.28%, and seem to be […]
Intellia Therapeutics Inc (NTLA) shares projected to rise by 281.11%
Intellia Therapeutics Inc [NTLA] stock is trading at $8.31, up 1.59%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. From an analyst’s perspective: Intellia Therapeutics Inc [NASDAQ: NTLA] stock has seen the most recent analyst activity on April 21, 2025, when Wolfe Research […]
There is no shortage of investors who are bullish on Intellia Therapeutics Inc (NTLA) stock
A share price of Intellia Therapeutics Inc [NTLA] is currently trading at $7.92, up 9.54%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NTLA shares have gain 6.88% over the last week, with a monthly amount drifted -8.97%, and not seem to be […]
Analysts’ expectations for Intellia Therapeutics Inc (NTLA) stock: $28.25 price target in 12 months
At the time of writing, Intellia Therapeutics Inc [NTLA] stock is trading at $7.41, up 9.45%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NTLA shares have gain 11.76% over the last week, with a monthly amount drifted -19.63%, and not seem to […]
Analysts predict Intellia Therapeutics Inc (NTLA) stock to reach $28.25 in the next 12 months
Intellia Therapeutics Inc [NTLA] stock is trading at $6.28, down -3.98%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NTLA shares have lost -5.63% over the last week, with a monthly amount drifted -33.62%, and not seem to be holding up […]